Essa Pharma announces $80M cash distribution to shareholders

Essa Pharma (EPIX) announced that, following the company’s receipt of an order from the Supreme Court of British Columbia on August 5, 2025, authorizing a reduction in the capital of the common shares of the company and concurrent distribution to the Shareholders, the board of directors of the company has approved a return of capital distribution in the aggregate amount of $80M to the Shareholders as part of the discontinuance and winding-up of the business of the company. The Distribution is scheduled to be paid on August 22 to Shareholders of record as of the close of business on August 19.